Important Safety Information
Indications for Use (IFU): The MRIdian Linac system, with magnetic resonance imaging capabilities, is intended to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated. The MRIdian Linac System is not appropriate for all patients, including those who are not candidates for magnetic resonance imaging.
Important Safety Information (ISI): Radiation treatments may cause side effects that can vary depending on the part of the body being treated. The most frequent ones are typically temporary and may include, but are not limited to, irritation to the respiratory, digestive, urinary or reproductive systems; fatigue; nausea; skin irritation; and hair loss. In some patients, side effects can be severe. Treatment sessions may vary in complexity and duration.
Radiation treatment is not appropriate for all cancers. You should discuss the potential for side effects and their severity as well as the benefits of radiation and magnetic resonance imaging with your doctor to make sure radiation treatment is right for you.
Disclaimer: The opinions and clinical experiences presented herein are specific to the featured physicians and the featured patients and are for information purposes only. Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations. Results of treatment presented in the videos and information on this webpage are not indicative of typical or future results.
Discuss treatment options with your doctor, including the risks and benefits of the entire course of treatment specific to your individual needs. MRIdian Linac systems are only available at appropriately equipped facilities with specially trained physicians.
A recent study of MRgRT at Amsterdam UMC found that patients with localized prostate cancer observed a low incidence of early GI and GU toxicity, both in clinician- and patient-reported outcome measurements.
Videos Related To Prostate Cancer
Neil Weissman, Prostate Cancer Survivor
Mr. Weissman shares his experience of being diagnosed with prostate cancer and treatment on the MRIdian by Dr. Himanshu Nagar and his team.
April 27, 2020
Jim Roper, Prostate Cancer Survivor
Mr. Roper shares his experience of being diagnosed with prostate cancer and treatment on the MRIdian by Dr. Himanshu Nagar and his team.
March 19, 2020
ViewRay MRIdian for Prostate, Breast, and Pancreatic Cancer Treatment
October 22, 2019
Scientific Presentations Related To Prostate Cancer
MR-Guided Daily Adaptive SBRT for Prostate Cancer – A Phase 2 Prospective Study
Ben Slotman, MD, PhD
Amsterdam University Medical Centers
ASTRO 2019
Dr. Slotman has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
MRI-Guided Prostate RT: See the Cancer, Spare the Toxicity
Himanshu Nagar, MD
The NewYork-Presbyterian Hospital and Weill Cornell Medicine
ASTRO 2019
Dr. Nagar has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
ViewRay SBRT of Prostate: Seeing is Believing
Prof. Jin Ho Kim, MD
Seoul National University Hospital
ASTRO 2019
Dr. Kim has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
Novel Applications for MRI-Guided Radiotherapy in the Treatment of Soft Tissue Sarcomas and Prostate Cancer
Zachary Morris, MD, PhD
Carbone Cancer Center, University of Wisconsin
ASTRO 2018
Dr. Morris has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
Post-Prostatectomy Radiotherapy: Roles for MRI-Guided RT
Amar Kishan, MD
UCLA Health, Jonsson Comprehensive Cancer Center
ASTRO 2018
Dr. Kishan has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
Benefits of MR-Guided Radiotherapy: Initial Clinical Experience with the ViewRay MRIdian System
Minsong Cao, Ph.D.
UCLA Health, Jonsson Comprehensive Cancer Center
AAPM 2018
Dr. Cao has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
On-Table Adaptive MR-Guided SBRT: Clinical Experience at VUmc
Ben Slotman, MD, PhD
VUmc – Amsterdam, The Netherlands
Advanced Applications of MR-Guided Radiotherapy Symposium (Amsterdam, 2018)
Dr. Slotman has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.